Lynn Institute of the Ozarks

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	NCT ID
To Evaluate the Safety and Efficacy of MANP in Subjects With Difficult to Control/ Resistant Hypertension	Difficult to Control Hypertension	Recruiting	Phase 2	2026-09-23	NCT06343298
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events	Infarction, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cardiovascular disorder, coronary artery disorder, heart disorder, ischemic disease, myocardial infarction, myocardial ischemia, vascular disorder	Recruiting	Phase 3	2026-08-21	NCT07136012
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy	Diabetic Peripheral Neuropathic Pain	Recruiting	Phase 3	2026-07-20	NCT07231419
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ≥18 Years of Age for the Prevention of Acute Gastroenteritis	Acute Gastroenteritis; Norovirus Acute Gastroenteritis	Active, not recruiting	Phase 3	2026-05-13	NCT06592794
Efficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus	Nutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, type 2 diabetes mellitus	Recruiting	Phase 2	2026-03-18	NCT07282743

Clinical trials